Clinical candidate selection finalised for lead programme targeting mast-cell driven diseases Dermatology industry veteran Thibaud Portal, PhD appointed as CEO LONDON, March 30, 2023 /PRNewswire/ — Granular Therapeutics, (Granular) a private biotech company specialising in precision…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.